Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer’s Disease and Cognitive Decline

The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly

(2019) Hui Xia et al.   JOURNAL OF ALZHEIMERS DISEASE

Tau Positron-Emission Tomography in Former National Football League Players

(2019) Robert A. Stern et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment

(2019) Katerina Cechova et al.   JOURNAL OF ALZHEIMERS DISEASE

BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention

(2017) Elizabeth A. Boots et al.   NEUROLOGY

Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism

(2017) Henrietta M. Nielsen et al.   Alzheimers Research & Therapy

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease

(2014) Y Y Lim et al.   MOLECULAR PSYCHIATRY

Amyloid and APOE  4 interact to influence short-term decline in preclinical Alzheimer disease

(2014) E. C. Mormino et al.   NEUROLOGY

Association of hypometabolism and amyloid levels in aging, normal subjects

(2014) V. J. Lowe et al.   NEUROLOGY

Preservation of General Intelligence following Traumatic Brain Injury: Contributions of the Met66 Brain-Derived Neurotrophic Factor

(2014) Aron K. Barbey et al.   PLoS One

Cerebrovascular risk factors and preclinical memory decline in healthy APOE  4 homozygotes

(2011) R. J. Caselli et al.   NEUROLOGY

Longitudinal modeling of frontal cognition in APOE  4 homozygotes, heterozygotes, and noncarriers

(2011) R. J. Caselli et al.   NEUROLOGY

Variant brain-derived neurotrophic factor Val66Met endophenotypes: implications for posttraumatic stress disorder

(2010) Helena Frielingsdorf et al.   Annals of the New York Academy of Sciences

APOE ε4 Genotype and Longitudinal Changes in Cerebral Blood Flow in Normal Aging

(2010) Madhav Thambisetty et al.   ARCHIVES OF NEUROLOGY

Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults

(2010) Tanja Richter-Schmidinger et al.   JOURNAL OF NEURAL TRANSMISSION

Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriers

(2010) Winnie S. Liang et al.   NEUROIMAGE

Effects of BDNF Val66Met polymorphism on brain metabolism in Alzheimerʼs disease

(2010) Cunlu Xu et al.   NEUROREPORT

Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age

(2009) Eloise Kok et al.   ANNALS OF NEUROLOGY

APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

(2009) John C. Morris et al.   ANNALS OF NEUROLOGY

Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

(2009) Jessica B.S. Langbaum et al.   NEUROIMAGE

Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition

(2009) C. Beste et al.   NEUROSCIENCE

Longitudinal Modeling of Age-Related Memory Decline and theAPOEε4 Effect

(2009) Richard J. Caselli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fibrillar amyloid-  burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

(2009) E. M. Reiman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA